Global reach BioDerm’s urinary management and securement products are sold in over 20 countries, indicating strong international demand and potential for expansion through distributors, partnerships, or direct sales in additional regions.

Healthcare settings With Men’s Liberty Acute and CathGrip options targeting hospitals and institutional care, there is a clear opportunity to expand sales to healthcare systems, ambulatory networks, and long-term care facilities seeking CAUTI reduction and improved catheter management.

Direct to consumer Recent direct-to-consumer campaigns for UriCap Female suggest growing consumer-facing channels; capitalizing on D2C opportunities could broaden patient-led demand and create alternative entry points for product adoption.

Protective solutions A strong portfolio around skin protection and adhesive management (FreeDerm Remover, Nano-grade adhesives, and BioPlus prep wipes) positions BioDerm to upsell to wound care, dermatology, and homecare distributors seeking comprehensive skin-safe solutions.

Operational shifts Notable headcount reduction indicates potential capacity constraints or strategic realignment; sales efforts should account for transition timelines, identify high-margin SKUs, and pursue partnerships that can sustain growth during organizational changes.